openPR Logo
Press release

Dermatophytic Onychomycosis Therapeutics Market: Global Market Intelligence

02-11-2017 01:03 AM CET | Health & Medicine

Press release from: Transparency Market Research - Pharmaceutical

Dermatophytic Onychomycosis Therapeutics Market: Global

Dermatophytic onychomycosis also referred to as ringworm of the nail is one of the most common fungal infections of the nails. This infection results in the change in appearance of the nails such as, increased opaqueness and whitening along with increased thickening and fragility. Tinea unguium specifically describes the dermatophytic invasion of the nail plates and is the most common in cases when an artificial nail is applied as the nails are abraded with the help of an emery board and these boards have a probability of carrying infection and also water collection under the nail results in creation of moist and warm environment favorable for fungal growth. Toenails are more commonly affected than finger nails. Onychomycosis infections accounts for one third of fungal skin infections and the diagnosis can be facilitated with the help of direct microscopy imaging of potassium hydroxide preparation or culture before opting for the treatment of the infection. The occurrence of this infection is more common in the adults aged 50 years and above.

Download Exclusive Brochure of This Report :
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2859

This infection can lead to serious health conditions such as it can decrease the peripheral circulation and would result in the conditions such as diabetic foot ulcers, and venous stasis. There are three main classes of organisms that cause onychomycosis namely, dermatophytes (fungi), nondermatophyte molds and yeast. Infection resulting from all these three classes of organisms cause similar symptoms along with similar visual appearance. Dermatophytes such as Microsporum, Epidermophyton and Trichophyton species are the most common dermatophytes responsible for infection and are the most common cause of onychomycosis worldwide. Whereas nondermatophyte molds and yeasts are less common causes of infection accounting for around 2% and 8% of the total onychomycosis infections.

The five major subtypes of onychomycosis are as follows:
White superficial onychomycosis (WSO)
Candidal onychomycosis
Distal lateral subungual onychomycosis (DLSO)
Proximal subungual onychomycosis (PSO)
Endonyx onychomycosis
Patients may suffer from a combination of three subtypes of infection and the features of these sub types vary from each other. Topical and oral medications are administered for treatment of onychomycosis infections. Topical medications includes the use of Ciclopirox olamine 8% nail lacquer solution, Amorolfine or bifonazole while oral medications includes the use of Itraconazole, Terbinafine and Flucanazole. Also there are certain non-pharmacological treatments such as photodynamic therapy, laser treatment, and mechanical chemical or surgical nail avulsion.

Dermatophytic onychomycosis infection therapeutics market can be segmented on the basis of various treatment options available such pharmacological and non-pharmacological treatment options. Further these segments can be categorized on the basis of types of the treatment available such as oral medications or drugs and topical medications. Also, a detailed geographical landscape elucidating the market trends for four major geographies such as North America, Europe, Asia-Pacific and RoW can be provided. In addition, an analysis of key events influencing the market trends and detailed vendor landscape of the market can also be provided.

Some of the major factors influencing the market growth are consistent rise in the prevalence of onychomycosis infections worldwide along with development of novel medications available commercially for the treatment of onychomycosis infections. In addition, consistent rise in geriatric population who are highly susceptible for acquiring the infections along with rise in treatment rate owing to increasing socialization of the individuals are some of the factors that would further drive the dermatophytic onychomycosis infections therapeutics market. On the other hand, increased circulation of off label products and negligence towards this infection especially in less developed economies would impede the market growth. Some of the key players operating in the Dermatophytic Onychomycosis Therapeutics market are Janssen Biotech, Novartis International AG, Pfizer, Inc. and Anacor pharmaceuticals, Inc.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments
Browse Global Strategic Business Report: http://www.transparencymarketresearch.com/klebsiella-pneumoniae-infections-treatment.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dermatophytic Onychomycosis Therapeutics Market: Global Market Intelligence here

News-ID: 435048 • Views: 1653

More Releases from Transparency Market Research - Pharmaceutical

Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Global Neurovascular Devices Market: Overview The global population is aging rapidly. According to WHO, the chances of health risks are greater in geriatric people than the young generation. Old age is considered to be one of the biggest risk factors that are responsible for developing various diseases such as cardiovascular and neurological conditions. It is because of these factors, the global neurovascular devices market is experiencing robust growth in the
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2 …
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from …
Swab and Viral Transport Medium Market: Introduction Transparency Market Research has published a new report titled, ‘Global Swab and Viral Transport Medium Market ’. According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030. Viral transport medium (VTM) enables safe transfer of viruses, chlamydia, and mycoplasma for
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027. Overview Radiofrequency ablation is a minimally invasive surgical

All 5 Releases


More Releases for Dermatophytic

Dermatophytic Onychomycosis Therapeutics (DOT) Market
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin
New Report Shares Details about the Dermatophytic Onychomycosis Therapeutics Mar …
Dermatophytic onychomycosis also referred to as ringworm of the nail is one of the most common fungal infections of the nails. This infection results in the change in appearance of the nails such as, increased opaqueness and whitening along with increased thickening and fragility. Tinea unguium specifically describes the dermatophytic invasion of the nail plates and is the most common in cases when an artificial nail is applied as the
Dermatophytic Onychomycosis Market Growth Analysis 2021
Persistence Market Research (PMR) delivers key insights on The Global Dermatophytic Onychomycosis Therapeutics Market in its latest report titled “Global Market Study on Dermatophytic Onychomycosis Therapeutics (DOT): North America Expected to Account for Maximum Market Share by 2021”. The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again
Global Dermatophytic Onychomycosis Market Growth Analysis 2021
Persistence Market Research (PMR) delivers key insights on The Global Dermatophytic Onychomycosis Therapeutics Market in its latest report titled “Global Market Study on Dermatophytic Onychomycosis Therapeutics (DOT): North America Expected to Account for Maximum Market Share by 2021”. The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again
Global Dermatophytic Onychomycosis Therapeutics CAGR of 8.3 % Modest By 2024
The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR of 8.3% during the
Dermatophytic Onychomycosis Market : Topical segment to account 70% share
The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR of 8.3% during the